Preliminary investigation of gene expression levels of PAPP-A, STC-2, and HIF-1α in SARS-Cov-2 infected patients.


Journal

Molecular biology reports
ISSN: 1573-4978
Titre abrégé: Mol Biol Rep
Pays: Netherlands
ID NLM: 0403234

Informations de publication

Date de publication:
Sep 2022
Historique:
received: 31 03 2022
accepted: 14 06 2022
pubmed: 8 7 2022
medline: 14 9 2022
entrez: 7 7 2022
Statut: ppublish

Résumé

Coronavirus-19 is still considered a pandemic that influences the world. Other molecular alterations should be clearer besides the increasing cytokine storm and pro-inflammatory molecules. Hypoxic conditions that induce HIF-1α lead to stimulate gene expression of STC-2 that targets PAPP-A expression. This study aimed to determine gene expression levels of PAPP-A, STC-2, and HIF-1α in COVID-19 infection. We also aimed to reveal the relationship of these genes with laboratory and clinical data of COVID-19 patients. We extracted RNA from peripheral blood samples of COVID-19(+) and COVID-19(-) individuals. The real-time PCR method was used to measure mRNA expression of PAPP-A, STC-2, and HIF-1α. Gene expression analysis was evaluated by the 2 This is the first study that investigates the relation of PAPP-A, STC-2, and HIF-1α gene expression in patients with COVID-19 infection. Besides the routine laboratory findings, PAPP-A, STC-2, and HIF-1α mRNA expressions may be considered to patients' prognosis as a sign of increased cytokines and pro-inflammatory molecules.

Sections du résumé

BACKGROUND BACKGROUND
Coronavirus-19 is still considered a pandemic that influences the world. Other molecular alterations should be clearer besides the increasing cytokine storm and pro-inflammatory molecules. Hypoxic conditions that induce HIF-1α lead to stimulate gene expression of STC-2 that targets PAPP-A expression. This study aimed to determine gene expression levels of PAPP-A, STC-2, and HIF-1α in COVID-19 infection. We also aimed to reveal the relationship of these genes with laboratory and clinical data of COVID-19 patients.
MATERIALS AND RESULTS RESULTS
We extracted RNA from peripheral blood samples of COVID-19(+) and COVID-19(-) individuals. The real-time PCR method was used to measure mRNA expression of PAPP-A, STC-2, and HIF-1α. Gene expression analysis was evaluated by the 2
CONCLUSION CONCLUSIONS
This is the first study that investigates the relation of PAPP-A, STC-2, and HIF-1α gene expression in patients with COVID-19 infection. Besides the routine laboratory findings, PAPP-A, STC-2, and HIF-1α mRNA expressions may be considered to patients' prognosis as a sign of increased cytokines and pro-inflammatory molecules.

Identifiants

pubmed: 35796937
doi: 10.1007/s11033-022-07710-9
pii: 10.1007/s11033-022-07710-9
pmc: PMC9261127
doi:

Substances chimiques

Glycoproteins 0
HIF1A protein, human 0
Hypoxia-Inducible Factor 1, alpha Subunit 0
Intercellular Signaling Peptides and Proteins 0
RNA, Messenger 0
STC2 protein, human 0
Pregnancy-Associated Plasma Protein-A EC 3.4.24.-
PAPPA protein, human EC 3.4.24.79

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8693-8699

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Références

Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet 395:497–506. https://doi.org/10.1016/S0140-6736(20)30183-5
doi: 10.1016/S0140-6736(20)30183-5
Boldt HB, Overgaard MT, Laursen LS et al (2001) Mutational analysis of the proteolytic domain of pregnancy-associated plasma protein-A (PAPP-A): classification as a metzincin. Biochem J 358:359. https://doi.org/10.1042/0264-6021:3580359
doi: 10.1042/0264-6021:3580359 pubmed: 11513734 pmcid: 1222068
Conover CA, Chen B-K, Resch ZT (2004) Regulation of pregnancy-associated plasma protein-A expression in cultured human osteoblasts. Bone 34:297–302. https://doi.org/10.1016/j.bone.2003.10.011
doi: 10.1016/j.bone.2003.10.011 pubmed: 14962808
Conover CA, Bale LK, Harrington SC et al (2006) Cytokine stimulation of pregnancy-associated plasma protein A expression in human coronary artery smooth muscle cells: inhibition by resveratrol. Am J Physiol Physiol 290:C183–C188. https://doi.org/10.1152/ajpcell.00199.2005
doi: 10.1152/ajpcell.00199.2005
Conover CA, Faessen GF, Ilg KE et al (2001) Pregnancy-associated plasma protein-A is the insulin-like growth factor binding protein-4 protease secreted by human ovarian granulosa cells and is a marker of Dominant follicle selection and the corpus luteum. Endocrinology 142:2155–2155. https://doi.org/10.1210/endo.142.5.8286
doi: 10.1210/endo.142.5.8286 pubmed: 11316785
Resch ZT, Chen B-K, Bale LK et al (2004) Pregnancy-associated plasma protein A gene expression as a target of inflammatory cytokines. Endocrinology 145:1124–1129. https://doi.org/10.1210/en.2003-1313
doi: 10.1210/en.2003-1313 pubmed: 14657012
Conover CA, Harrington SC, Bale LK, Oxvig C (2007) Surface association of pregnancy-associated plasma protein-A accounts for its colocalization with activated macrophages. Am J Physiol Circ Physiol 292:H994–H1000. https://doi.org/10.1152/ajpheart.00798.2006
doi: 10.1152/ajpheart.00798.2006
Chang AC-M, Reddel RR (1998) Identification of a second stanniocalcin cDNA in mouse and human: stanniocalcin 2. Mol Cell Endocrinol 141:95–99. https://doi.org/10.1016/S0303-7207(98)00097-5
doi: 10.1016/S0303-7207(98)00097-5 pubmed: 9723890
Ishibashi K, Miyamoto K, Taketani Y et al (1998) Molecular cloning of a second human stanniocalcin homologue (STC2). Biochem Biophys Res Commun 250:252–258. https://doi.org/10.1006/bbrc.1998.9300
doi: 10.1006/bbrc.1998.9300 pubmed: 9753616
Jepsen MR, Kløverpris S, Mikkelsen JH et al (2015) Stanniocalcin-2 inhibits mammalian growth by proteolytic inhibition of the insulin-like growth factor axis. J Biol Chem 290:3430–3439. https://doi.org/10.1074/jbc.M114.611665
doi: 10.1074/jbc.M114.611665 pubmed: 25533459
Law AYS, Lai KP, Ip CKM et al (2008) Epigenetic and HIF-1 regulation of stanniocalcin-2 expression in human cancer cells. Exp Cell Res 314:1823–1830. https://doi.org/10.1016/j.yexcr.2008.03.001
doi: 10.1016/j.yexcr.2008.03.001 pubmed: 18394600
Ito D, Walker JR, Thompson CS et al (2004) Characterization of stanniocalcin 2, a novel target of the mammalian unfolded protein response with cytoprotective properties. Mol Cell Biol 24:9456–9469. https://doi.org/10.1128/MCB.24.21.9456-9469.2004
doi: 10.1128/MCB.24.21.9456-9469.2004 pubmed: 15485913 pmcid: 522226
Eltzschig HK, Carmeliet P (2011) Hypoxia and inflammation. N Engl J Med 364:656–665. https://doi.org/10.1056/NEJMra0910283
doi: 10.1056/NEJMra0910283 pubmed: 21323543 pmcid: 3930928
Van Wyngene L, Vandewalle J, Libert C (2018) Reprogramming of basic metabolic pathways in microbial sepsis: therapeutic targets at last? EMBO Mol Med 10:e8712. https://doi.org/10.15252/emmm.201708712
doi: 10.15252/emmm.201708712 pubmed: 29976786 pmcid: 6079534
Fitzpatrick SF (2019) Immunometabolism and sepsis: a role for HIF? Front Mol Biosci 6:e00085. https://doi.org/10.3389/fmolb.2019.00085
doi: 10.3389/fmolb.2019.00085
Semenza GL, Jiang B-H, Leung SW et al (1996) Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 271:32529–32537. https://doi.org/10.1074/jbc.271.51.32529
doi: 10.1074/jbc.271.51.32529 pubmed: 8955077
Adams J, Difazio L, Rolandelli R et al (2009) HIF-1: a key mediator in hypoxia (Review). Acta Physiol Hung 96:19–28. https://doi.org/10.1556/APhysiol.96.2009.1.2
doi: 10.1556/APhysiol.96.2009.1.2 pubmed: 19264039
Yoon D, Pastore YD, Divoky V et al (2006) Hypoxia-inducible Factor-1 deficiency results in dysregulated erythropoiesis signaling and iron homeostasis in mouse development. J Biol Chem 281:25703–25711. https://doi.org/10.1074/jbc.M602329200
doi: 10.1074/jbc.M602329200 pubmed: 16787915
Kallio PJ (1998) Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha. EMBO J 17:6573–6586. https://doi.org/10.1093/emboj/17.22.6573
doi: 10.1093/emboj/17.22.6573 pubmed: 9822602 pmcid: 1171004
Prabhakar NR (2001) Invited review: oxygen sensing during intermittent hypoxia: cellular and molecular mechanisms. J Appl Physiol 90:1986–1994. https://doi.org/10.1152/jappl.2001.90.5.1986
doi: 10.1152/jappl.2001.90.5.1986 pubmed: 11299293
Schäfer ST, Frede S, Winning S et al (2013) Hypoxia-inducible factor and target gene expression are decreased in patients with sepsis. Anesthesiology 118:1426–1436. https://doi.org/10.1097/ALN.0b013e31828baa67
doi: 10.1097/ALN.0b013e31828baa67 pubmed: 23449494
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods 25:402–408. https://doi.org/10.1006/meth.2001.1262
doi: 10.1006/meth.2001.1262 pubmed: 11846609
Conover CA, Oxvig C (2017) PAPP-A: a promising therapeutic target for healthy longevity. Aging Cell 16:205–209. https://doi.org/10.1111/acel.12564
doi: 10.1111/acel.12564 pubmed: 28035757
Sanchez BG, Gasalla JM, Sánchez-Chapado M et al (2021) Increase in ischemia-modified albumin and pregnancy-associated plasma protein-A in COVID-19 patients. J Clin Med 10:5474. https://doi.org/10.3390/jcm10235474
doi: 10.3390/jcm10235474 pubmed: 34884175 pmcid: 8658290
Cosma S, Carosso AR, Borella F et al (2021) Prenatal biochemical and ultrasound markers in COVID-19 pregnant patients: a prospective case-control study. Diagnostics 11:398. https://doi.org/10.3390/diagnostics11030398
doi: 10.3390/diagnostics11030398 pubmed: 33652805 pmcid: 7996827
Trilla C, Mora J, Crovetto F et al (2022) First-trimester SARS-CoV-2 infection: clinical presentation, inflammatory markers and obstetric outcomes. Fetal Diagn Ther. https://doi.org/10.1159/000523974
doi: 10.1159/000523974 pubmed: 35263747
Serrano B, Mendoza M, Garcia-Aguilar P et al (2022) Shared risk factors for COVID-19 and preeclampsia in the first trimester: an observational study. Acta Obstet Gynecol Scand. https://doi.org/10.1111/aogs.14371
doi: 10.1111/aogs.14371 pubmed: 35505629 pmcid: 9347999
Lv H, Liu Q, Sun Y et al (2020) Mesenchymal stromal cells ameliorate acute lung injury induced by LPS mainly through stanniocalcin-2 mediating macrophage polarization. Ann Transl Med 8:334–334. https://doi.org/10.21037/atm.2020.02.105
doi: 10.21037/atm.2020.02.105 pubmed: 32355778 pmcid: 7186596
Zhang L, Li M, Wang Z et al (2022) Cardiovascular risk after SARS-CoV-2 infection is mediated by IL18/IL18R1/HIF-1 signaling pathway axis. Front Immunol 12:e780804. https://doi.org/10.3389/fimmu.2021.780804
doi: 10.3389/fimmu.2021.780804
Taniguchi-Ponciano K, Vadillo E, Mayani H et al (2021) Increased expression of hypoxia-induced factor 1α mRNA and its related genes in myeloid blood cells from critically ill COVID-19 patients. Ann Med 53:197–207. https://doi.org/10.1080/07853890.2020.1858234
doi: 10.1080/07853890.2020.1858234 pubmed: 33345622
Codo AC, Davanzo GG, de Monteiro LB et al (2020) Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1α/glycolysis-dependent axis. Cell Metab 32:437-446.e5. https://doi.org/10.1016/j.cmet.2020.07.007
doi: 10.1016/j.cmet.2020.07.007 pubmed: 32697943 pmcid: 7367032
Zhu B, Wu Y, Huang S et al (2021) Uncoupling of macrophage inflammation from self-renewal modulates host recovery from respiratory viral infection. Immunity 54:1200-1218.e9. https://doi.org/10.1016/j.immuni.2021.04.001
doi: 10.1016/j.immuni.2021.04.001 pubmed: 33951416 pmcid: 8192557
Tian M, Liu W, Li X et al (2021) HIF-1α promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19. Signal Transduct Target Ther 6:308. https://doi.org/10.1038/s41392-021-00726-w
doi: 10.1038/s41392-021-00726-w pubmed: 34408131 pmcid: 8371950
Rolfo A, Cosma S, Nuzzo AM et al (2022) Increased placental anti-oxidant response in asymptomatic and symptomatic COVID-19 third-trimester pregnancies. Biomedicines 10:634. https://doi.org/10.3390/biomedicines10030634
doi: 10.3390/biomedicines10030634 pubmed: 35327436 pmcid: 8945802
Panagiotou G, Anastasilakis AD, Kynigopoulos G et al (2017) Physiological parameters regulating circulating levels of the IGFBP-4/Stanniocalcin-2/PAPP-A axis. Metabolism 75:16–24. https://doi.org/10.1016/j.metabol.2017.07.003
doi: 10.1016/j.metabol.2017.07.003 pubmed: 28964325
Ortega MA, Fraile-Martínez O, Asúnsolo Á et al (2020) Chronic venous disease patients showed altered expression of IGF-1/PAPP-A/STC-2 axis in the vein wall. Biomed Res Int 2020:1–8. https://doi.org/10.1155/2020/6782659
doi: 10.1155/2020/6782659
Hjortebjerg R, Bojsen-Møller KN, Søeby M et al (2021) Metabolic improvement after gastric bypass correlates with changes in IGF-regulatory proteins stanniocalcin-2 and IGFBP-4. Metabolism 124:154886. https://doi.org/10.1016/j.metabol.2021.154886
doi: 10.1016/j.metabol.2021.154886 pubmed: 34506805
Espelund US, Bjerre M, Hjortebjerg R et al (2017) Insulin-like growth factor bioactivity, stanniocalcin-2, pregnancy-associated plasma protein-A, and IGF-binding protein-4 in pleural fluid and serum from patients with pulmonary disease. J Clin Endocrinol Metab 102:3526–3534. https://doi.org/10.1210/jc.2017-00033
doi: 10.1210/jc.2017-00033 pubmed: 28911149
Iunusova N V, Spirina L V, Kondakova LA, et al [Relationship between the expression levels of PAPP-A metalloproteinase and growth and transcriptional factors in endometrial cancer]. Izv Akad Nauk Seriia Biol 284–91
Jin M, Shi N, Wang M et al (2020) CD45: a critical regulator in immune cells to predict severe and non-severe COVID-19 patients. Aging 12:19867–19879. https://doi.org/10.18632/aging.103941
doi: 10.18632/aging.103941 pubmed: 33065551 pmcid: 7655207

Auteurs

Sevgi Karabulut Uzunçakmak (S)

Health Services Vocational School, Bayburt University, 69000, Bayburt, Turkey. skarabulut@bayburt.edu.tr.

Muhammet Emin Naldan (ME)

Department of Anesthesia, Bilecik Seyh Edibali University, 11230, Bilecik, Turkey.

Ebubekir Dirican (E)

Health Services Vocational School, Bayburt University, 69000, Bayburt, Turkey.

Ferhan Kerget (F)

Department of Infectious and Clinical Microbiology Diseases, Erzurum Regional Education and Research Hospital, 25240, Erzurum, Turkey.

Zekai Halıcı (Z)

Department of Pharmacology, Ataturk University, 25240, Erzurum, Turkey.
Clinical Research, Development and Design Application and Research Center, Ataturk University, 25240, Erzurum, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH